(Q44813228)

6 December 2017

title

Photodynamic treatment with verteporfin for patients with idiopathic choroidal neovascularization. Two-year results (English)

1 reference

6 December 2017

1 reference

J Wachtlin

1

1 reference

6 December 2017

A Wehner

series ordinal

2

1 reference

6 December 2017

H Heimann

series ordinal

3

1 reference

6 December 2017

M H Foerster

series ordinal

4

1 reference

6 December 2017

language of work or name

German

0 references

publication date

1 May 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

101

1 reference

6 December 2017

issue

5

1 reference

6 December 2017

page(s)

489-495

1 reference

The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age.

6 December 2017

cites work

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

1 reference

12 December 2020

Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.

1 reference

12 December 2020

Concentric retinal pigment epithelium atrophy after a single photodynamic therapy

1 reference

12 December 2020

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes

1 reference

12 December 2020

Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Macular Photocoagulation Study Group

1 reference

12 December 2020

Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin

1 reference

12 December 2020

Idiopathic Focal Subretinal Neovascularization

1 reference

12 December 2020

Etiology of choroidal neovascularization in young patients

1 reference

12 December 2020

[The so-called "ocular histoplasmosis syndrome"]

1 reference

12 December 2020

Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks

1 reference

12 December 2020

Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks

1 reference

12 December 2020

Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases

1 reference

12 December 2020

Photodynamic therapy: extended indication

1 reference

12 December 2020

Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Macular Photocoagulation Study Group

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

12 December 2020

Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group

1 reference

12 December 2020

Krypton laser photocoagulation for idiopathic neovascular lesions. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

12 December 2020

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

12 December 2020

10.1007/S00347-004-0993-5

Identifiers

DOI

1 reference

6 December 2017

1 reference